Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMAG Pharmaceuticals Appoints VP | Contract Pharma
Promotions & Moves

AMAG Pharmaceuticals Appoints VP

Griffith responsible for the creation and implementation of AMAG’s medical communications and publication strategies

Nancy Griffith, Ph.D., has been appointed vice president, scientific communications and medical operations, AMAG Pharmaceuticals, Inc. Dr. Griffith reports to Brian Robinson, M.D., senior vice president, medical affairs, and will be responsible for the creation and implementation of AMAG’s medical communications and publication strategies.

“As AMAG continues to invest in development-stage assets such as AMAG-423 and ciraparantag, it is increasingly important to effectively communicate and publish the clinical data supporting these therapies,” said Dr. Robinson. “Dr. Griffith brings the leadership and expertise necessary to develop robust medical communications and publication strategies, adding value to our strategic medical affairs objectives.”

Dr. Griffith brings more than 20 years of publications and communications experience from both large and small pharmaceutical and biotechnology companies. Most recently she served as vice president, medical operations and communications at Wave Life Sciences where she established the medical affairs function to support pipeline growth, including the development and execution of medical communications, medical publications, medical information, and scientific writing for the company’s portfolio.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters